Related Experiment Videos
Gender-based differences and menstrual cycle-related changes in specific diseases: implications for pharmacotherapy
1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Pharmacotherapy
|May 16, 2000
Summary
Women experience significant gender-based and menstrual cycle-related health differences, particularly in asthma, arthritis, migraine, diabetes, depression, and epilepsy. Awareness and tracking symptoms can help manage these conditions.
Area of Science:
- Reproductive Endocrinology
- Women's Health
- Clinical Pharmacology
Background:
- Women generally report higher rates of physical illness and utilize healthcare services more frequently than men.
- These gender disparities are likely influenced by a complex interplay of biological, physiological, social, behavioral, psychological, and cultural factors.
- A notable percentage of women with specific chronic conditions experience premenstrual symptom exacerbation.
Purpose of the Study:
- To highlight gender-based differences and menstrual cycle-related changes in six common diseases.
- To inform pharmacists and healthcare providers about these variations for improved patient care.
- To explore potential therapeutic strategies for managing cycle-related exacerbations.
Main Methods:
- Review of existing literature on gender differences and menstrual cycle influences on disease presentation and management.
- Discussion of symptom tracking using menstrual calendars to identify cyclic trends.
- Exploration of pharmacotherapeutic interventions, including ovulation suppression and hormonal therapies.
Main Results:
- Women with asthma, arthritis, migraine, diabetes, depression, or epilepsy often experience premenstrual worsening of their conditions.
- The exact mechanisms for these cyclic exacerbations are not fully understood but are considered multifactorial.
- Symptom tracking and targeted pharmacotherapy, including GnRH analogs and hormonal therapies, show potential for managing these fluctuations.
Conclusions:
- Pharmacists and clinicians must recognize and address gender and menstrual cycle variations in managing these six diseases.
- Menstrual calendar tracking is a valuable tool for patients to anticipate and manage cyclic symptom flares.
- Advanced treatment options, including hormonal therapies and surgical interventions, may be considered for refractory cases, with ongoing research needed.